1 / 3

Metabolomics Market worth $2,100 Million by 2019.

Over the last decade, there has been a tremendous development in biochemistry and molecular biology which has had a positive impact on the overall growth of the metabolomics market. The market has witnessed the introduction of many advanced analytical equipment and data processing programs.

GauravG1411
Télécharger la présentation

Metabolomics Market worth $2,100 Million by 2019.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Metabolomics Market worth $2,100 Million by 2019. Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) Publish Date:- June 2014.

  2. The “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World. Browse 80 market data tables and 7 figures spread through 270 slides and in-depth TOC on "Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019" http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html Early buyers will receive 10% customization on reports. This report studies the metabolomics market over the forecast period of 2014 to 2019. The technological progress in biochemistry and molecular biology has played a significant role in the development of the metabolomics market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the metabolomics field. The presence of research funding and government support for conducting research and commercialization of the products in the metabolomics market is the primary driver for the growth of this market. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market. However, the lack of skilled professionals in metabolomics science is a significant restraint for the growth of the metabolomics market. The low adoption rate of metabolomics and data complexity are the other factors that are hindering the growth of the metabolomics market. In this report, the metabolomics market is segmented based on techniques, applications, indications, geographic regions, and countries. This report also discusses the key market drivers, restraints, and opportunities for this market and its sub-markets. The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019. Download FREE PDF Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=900 In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries. Ask for Sample Report:- http://www.marketsandmarkets.com/requestsample.asp?id=900 The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.). About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

  3. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact: Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-600-6441 Email: sales@marketsandmarkets.com

More Related